A detailed history of Point State Capital LP transactions in Natera, Inc. stock. As of the latest transaction made, Point State Capital LP holds 782,538 shares of NTRA stock, worth $125 Million. This represents 2.18% of its overall portfolio holdings.

Number of Shares
782,538
Previous 369,070 112.03%
Holding current value
$125 Million
Previous $40 Million 148.86%
% of portfolio
2.18%
Previous 1.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$97.75 - $129.67 $40.4 Million - $53.6 Million
413,468 Added 112.03%
782,538 $99.5 Million
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $31.5 Million - $41.6 Million
369,070 New
369,070 $40 Million
Q3 2021

Nov 15, 2021

SELL
$100.17 - $126.36 $1 Million - $1.26 Million
-10,000 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$86.05 - $119.72 $860,500 - $1.2 Million
10,000 New
10,000 $1.14 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.5B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Point State Capital LP Portfolio

Follow Point State Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Point State Capital LP with notifications on news.